Circulating biomarkers for prediction of immunotherapy response in NSCLC
KY Goh, TYD Cheng, SC Tham, DWT Lim - Biomedicines, 2023 - mdpi.com
Non-small cell lung cancer (NSCLC) constitutes the majority of the lung cancer population
and the prognosis is poor. In recent years, immunotherapy has become the standard of care …
and the prognosis is poor. In recent years, immunotherapy has become the standard of care …
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
YT Tsai, J Schlom, RN Donahue - Journal of Experimental & Clinical …, 2024 - Springer
The paradigm of non-small cell lung cancer (NSCLC) treatment has been profoundly
influenced by the development of immune checkpoint inhibitors (ICI), but the range of clinical …
influenced by the development of immune checkpoint inhibitors (ICI), but the range of clinical …
miR-Blood–a small RNA atlas of human blood components
Abstract miR-Blood is a high-quality, small RNA expression atlas for the major components
of human peripheral blood (plasma, erythrocytes, thrombocytes, monocytes, neutrophils …
of human peripheral blood (plasma, erythrocytes, thrombocytes, monocytes, neutrophils …
[HTML][HTML] Unravelling the puzzle of immunotherapeutic efficacy in lung cancer
P Christopoulos - Translational Lung Cancer Research, 2024 - ncbi.nlm.nih.gov
© Translational Lung Cancer Research. All rights reserved. Transl Lung Cancer Res 2024;
13 (5): 1173-1176| https://dx. doi. org/10.21037/tlcr-24-221 which complicates statistical …
13 (5): 1173-1176| https://dx. doi. org/10.21037/tlcr-24-221 which complicates statistical …
Applying artificial intelligence prediction tools for advancing precision oncology in immunotherapy: future perspectives in personalized care
Artificial intelligence (AI) has revolutionized the medical field more evidently in managing
and treating cancer as it continues to be a global burden. Artificial intelligence has been …
and treating cancer as it continues to be a global burden. Artificial intelligence has been …
[HTML][HTML] MicroRNA-155 as Biomarker and Its Diagnostic Value in Breast Cancer: A Systematic Review
BS Yeo, WX Lee, R Mahmud, GC Tan… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
The investigation of microRNAs (miRNAs) for the purpose of identifying biomarkers and new
treatments for breast cancer has been gaining traction from scientists in recent years. Of all …
treatments for breast cancer has been gaining traction from scientists in recent years. Of all …
[PDF][PDF] Investigating the relationship between transcriptomic markers, and burn wound healing and scarring outcomes
MC Siu - 2023 - eprints.qut.edu.au
This study identified miRNAs, genes and biological pathways associated with wound
healing and scarring in children with burn injuries. The miRNAs and genes which were …
healing and scarring in children with burn injuries. The miRNAs and genes which were …